SCHEMBL181556

SCHEMBL181556

CC(C)COC(C)OC=CC(N)=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
MAP3K7 O43318 2/20 0.33
TAB1 Q15750 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2832059 0.76 TSHR (0.38) TSHRMAP3K7TAB1ALDH1A1MAPT
SCHEMBL248080 0.70 TSHR (0.33) TSHRMAP3K7TAB1ALDH1A1MAPT
SCHEMBL11806922 0.70 TSHR (0.42) TSHRALDH1A1MAPT
SCHEMBL905728 0.69 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL5838096 0.68 HCAR2 (0.43) TSHRALDH1A1
SCHEMBL9363971 0.67 TSHR (0.55) TSHRMAP3K7TAB1ALDH1A1MAPT
SCHEMBL181415 0.67 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL6379498 0.66
SCHEMBL181416 0.65 LMNA (0.32) TSHR
SCHEMBL8649318 0.65 MAP3K7 (0.38) TSHRMAP3K7TAB1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed
EP-2401257-A1 ENZYME INHIBITORS Chroma Therapeutics Ltd. (GB) 2012-01-04 EP disclosed